Literature DB >> 21537953

Successful surgical intervention for the management of endocarditis due to multidrug resistant Candida parapsilosis: case report and literature review.

Jessica Kumar1, Douglas Fish, Harold Burger, Barbara Weiser, Jeffrey S Ross, David Jones, Karl Robstad, Xiaojiang Li, Vishnu Chaturvedi.   

Abstract

Candida parapsilosis is an uncommon cause of invasive endocarditis. This pathogen induces severe complications and carries a high mortality rate. We describe a case of C. parapsilosis endocarditis in a 54-year-old man with a history of HIV and Hepatitis C infection who previously underwent prosthetic valve replacement due to bacterial endocarditis. The patient presented with prolonged febrile episodes and fungemia with repeat blood cultures positive for C. parapsilosis. The patient failed multiple regimens of antifungal therapy and the C. parapsilosis isolate progressively acquired resistance to a number of drugs. Due to the multidrug resistant nature of the isolate, replacement of the infected valve was required to resolve his fungemia, and the patient remained asymptomatic for two years. This case is unusual due to the multidrug resistant nature of the isolate requiring both combined medical and surgical intervention. A review of published reports indicates that endocarditis due to C. parapsilosis responds well to a combination of medical and surgical interventions; the latter is particularly suitable for immunocompromised hosts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537953     DOI: 10.1007/s11046-011-9430-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  27 in total

1.  A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.

Authors:  T Lejko-Zupanc; M Kozelj
Journal:  J Infect       Date:  1997-07       Impact factor: 6.072

2.  Candida parapsilosis endocarditis 8 months after transient candidemia.

Authors:  Mutahir U Khan; Shaukat Ali; Muhammad A Baig; Muhammad A Rafiq; Balendu C Vasavada; Ijaz A Khan
Journal:  Int J Cardiol       Date:  2007-03-28       Impact factor: 4.164

3.  Candida parapsilosis endocarditis in aged patient.

Authors:  Juan Marti
Journal:  Eur J Intern Med       Date:  2008-08-28       Impact factor: 4.487

4.  Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains.

Authors:  C Girmenia; P Martino; F De Bernardis; G Gentile; M Boccanera; M Monaco; G Antonucci; A Cassone
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

5.  Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.

Authors:  L E Samelson; S A Lerner; L Resnekov; C Anagnostopoulos
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

6.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

7.  Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.

Authors:  Varsha Moudgal; Tania Little; Dina Boikov; Jose A Vazquez
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  A meta-analysis of medical versus surgical therapy for Candida endocarditis.

Authors:  William J Steinbach; John R Perfect; Christopher H Cabell; Vance G Fowler; G Ralph Corey; Jennifer S Li; Aimee K Zaas; Daniel K Benjamin
Journal:  J Infect       Date:  2004-12-01       Impact factor: 6.072

9.  Ultrastructure of Candida parapsilosis endocarditis.

Authors:  T J Marrie; J H Cooper; J W Costerton
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Candidemia in neonatal intensive care units: Barcelona, Spain.

Authors:  Dolors Rodriguez; Benito Almirante; Benjamin J Park; Manuel Cuenca-Estrella; Ana M Planes; Ferran Sanchez; Amadeu Gene; Mariona Xercavins; Dionisia Fontanals; Juan L Rodriguez-Tudela; David W Warnock; Albert Pahissa
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

View more
  3 in total

1.  Fungal Prosthetic Valve Endocarditis by Candida parapsilosis: A Case Report.

Authors:  Tahereh Shokohi; Seyed Mahmood Nouraei; Mohammad Hosein Afsarian; Narges Najafi; Shirin Mehdipour
Journal:  Jundishapur J Microbiol       Date:  2014-03-01       Impact factor: 0.747

2.  A case series of medically managed Candida parapsilosis complex prosthetic valve endocarditis.

Authors:  Penghao Guo; Yuting He; Rui Fan; Zhongwen Wu; Yili Chen; Yuli Huang; Kang Liao; Peisong Chen
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-01-05       Impact factor: 3.944

3.  Candida parapsilosis prosthetic valve endocarditis.

Authors:  André Silva-Pinto; Rita Ferraz; Jorge Casanova; António Sarmento; Lurdes Santos
Journal:  Med Mycol Case Rep       Date:  2015-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.